RZLT
Price
$4.03
Change
+$0.02 (+0.50%)
Updated
May 22, 12:54 PM (EDT)
Capitalization
342.93M
112 days until earnings call
XNCR
Price
$7.46
Change
-$0.06 (-0.80%)
Updated
May 22, 12:59 PM (EDT)
Capitalization
535.2M
69 days until earnings call
Interact to see
Advertisement

RZLT vs XNCR

Header iconRZLT vs XNCR Comparison
Open Charts RZLT vs XNCRBanner chart's image
Rezolute
Price$4.03
Change+$0.02 (+0.50%)
Volume$100
Capitalization342.93M
Xencor
Price$7.46
Change-$0.06 (-0.80%)
Volume$12.29K
Capitalization535.2M
RZLT vs XNCR Comparison Chart
Loading...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RZLT vs. XNCR commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RZLT is a Hold and XNCR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (RZLT: $4.01 vs. XNCR: $7.52)
Brand notoriety: RZLT and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RZLT: 179% vs. XNCR: 92%
Market capitalization -- RZLT: $342.93M vs. XNCR: $535.2M
RZLT [@Biotechnology] is valued at $342.93M. XNCR’s [@Biotechnology] market capitalization is $535.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RZLT’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • RZLT’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, RZLT is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RZLT’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • RZLT’s TA Score: 5 bullish, 5 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both RZLT and XNCR are a good buy in the short-term.

Price Growth

RZLT (@Biotechnology) experienced а +14.90% price change this week, while XNCR (@Biotechnology) price change was -7.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

RZLT is expected to report earnings on Sep 11, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($535M) has a higher market cap than RZLT($343M). RZLT YTD gains are higher at: -18.163 vs. XNCR (-67.276). RZLT has higher annual earnings (EBITDA): -73.3M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. RZLT (96.5M). RZLT has less debt than XNCR: RZLT (1.93M) vs XNCR (67.8M). XNCR has higher revenues than RZLT: XNCR (127M) vs RZLT (0).
RZLTXNCRRZLT / XNCR
Capitalization343M535M64%
EBITDA-73.3M-161.68M45%
Gain YTD-18.163-67.27627%
P/E RatioN/AN/A-
Revenue0127M-
Total Cash96.5M470M21%
Total Debt1.93M67.8M3%
FUNDAMENTALS RATINGS
RZLT vs XNCR: Fundamental Ratings
RZLT
XNCR
OUTLOOK RATING
1..100
264
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4194
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (46) in the null industry is in the same range as XNCR (78) in the Biotechnology industry. This means that RZLT’s stock grew similarly to XNCR’s over the last 12 months.

RZLT's Profit vs Risk Rating (96) in the null industry is in the same range as XNCR (100) in the Biotechnology industry. This means that RZLT’s stock grew similarly to XNCR’s over the last 12 months.

RZLT's SMR Rating (100) in the null industry is in the same range as XNCR (100) in the Biotechnology industry. This means that RZLT’s stock grew similarly to XNCR’s over the last 12 months.

RZLT's Price Growth Rating (41) in the null industry is somewhat better than the same rating for XNCR (94) in the Biotechnology industry. This means that RZLT’s stock grew somewhat faster than XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for RZLT (100) in the null industry. This means that XNCR’s stock grew significantly faster than RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RZLTXNCR
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 16 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRMAX27.65N/A
N/A
Nationwide S&P 500 Index A
FMAMX78.32N/A
N/A
Fidelity Advisor Stock Sel A
AWTIX20.20N/A
N/A
Virtus Duff & Phelps Water Inst
BMIIX7.03N/A
N/A
BNY Mellon Income Stock I
RYIAX128.47N/A
N/A
Rydex Internet H

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+1.52%
RLAY - RZLT
40%
Loosely correlated
-6.23%
RCKT - RZLT
37%
Loosely correlated
-3.80%
OCGN - RZLT
36%
Loosely correlated
+2.47%
XNCR - RZLT
36%
Loosely correlated
-7.62%
ANNX - RZLT
35%
Loosely correlated
-6.19%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RCKT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-7.62%
RCKT - XNCR
60%
Loosely correlated
-3.80%
CRNX - XNCR
58%
Loosely correlated
-4.53%
ERAS - XNCR
58%
Loosely correlated
-4.69%
BEAM - XNCR
56%
Loosely correlated
-2.99%
ACLX - XNCR
54%
Loosely correlated
+8.26%
More